TCL Archive In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi March 9, 1984
TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012